Animal models of Alzheimer's disease and frontotemporal dementia (Q37196122)

18 August 2017

1 reference

title

Animal models of Alzheimer's disease and frontotemporal dementia (English)

1 reference

18 August 2017

0 references

0 references

frontotemporal dementia

1 reference

2

1 reference

18 August 2017

Jürgen Götz

1

0 references

language of work or name

English

0 references

publication date

1 July 2008

1 reference

Nature Reviews Neuroscience

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

532-544

1 reference

18 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn2420

18 August 2017

0 references

cites work

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

1 reference

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

31 March 2020

1 reference

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

31 March 2020

1 reference

Distinct behavioural profiles in frontotemporal dementia and semantic dementia

31 March 2020

1 reference

Frontotemporal dementias: a review

31 March 2020

1 reference

Alzheimer's disease is a synaptic failure

31 March 2020

1 reference

Neurodegenerative tauopathies

31 March 2020

1 reference

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

31 March 2020

1 reference

A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease

31 March 2020

1 reference

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

31 March 2020

1 reference

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

31 March 2020

1 reference

The genetic epidemiology of neurodegenerative disease

31 March 2020

1 reference

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

31 March 2020

1 reference

Tau is a candidate gene for chromosome 17 frontotemporal dementia

31 March 2020

1 reference

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

31 March 2020

1 reference

Loss of progranulin function in frontotemporal lobar degeneration

31 March 2020

1 reference

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

31 March 2020

1 reference

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

31 March 2020

1 reference

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

31 March 2020

1 reference

TDP-43 A315T mutation in familial motor neuron disease

31 March 2020

1 reference

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

31 March 2020

1 reference

TDP-43 mutation in familial amyotrophic lateral sclerosis

31 March 2020

1 reference

Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane

31 March 2020

1 reference

TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.

31 March 2020

1 reference

Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene.

31 March 2020

1 reference

A decade of tau transgenic animal models and beyond

31 March 2020

1 reference

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

31 March 2020

1 reference

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

31 March 2020

1 reference

Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.

31 March 2020

1 reference

Tau suppression in a neurodegenerative mouse model improves memory function

31 March 2020

1 reference

Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.

31 March 2020

1 reference

Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration.

31 March 2020

1 reference

Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.

31 March 2020

1 reference

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

31 March 2020

1 reference

Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein

31 March 2020

1 reference

Tau and transgenic animal models

31 March 2020

1 reference

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

31 March 2020

1 reference

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

31 March 2020

1 reference

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

31 March 2020

1 reference

Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice

31 March 2020

1 reference

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

31 March 2020

1 reference

Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.

31 March 2020

1 reference

The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production

31 March 2020

1 reference

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

31 March 2020

1 reference

Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model

31 March 2020

1 reference

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

31 March 2020

1 reference

Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease

31 March 2020

1 reference

Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology.

31 March 2020

1 reference

BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease

31 March 2020

1 reference

Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice

31 March 2020

1 reference

beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice

31 March 2020

1 reference

Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity.

31 March 2020

1 reference

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

31 March 2020

1 reference

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

31 March 2020

1 reference

Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease

31 March 2020

1 reference

Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease

31 March 2020

1 reference

Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice

31 March 2020

1 reference

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

31 March 2020

1 reference

Molecular motors and mechanisms of directional transport in neurons

31 March 2020

1 reference

Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform

31 March 2020

1 reference

Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease

31 March 2020

1 reference

Differential regulation of dynein and kinesin motor proteins by tau

31 March 2020

1 reference

Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I

31 March 2020

1 reference

Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP

31 March 2020

1 reference

A century of Alzheimer's disease

31 March 2020

1 reference

Interaction of tau protein with the dynactin complex

31 March 2020

1 reference

Dying for a cause: invertebrate genetics takes on human neurodegeneration

31 March 2020

1 reference

Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles

31 March 2020

1 reference

Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila

31 March 2020

1 reference

Oxidative stress mediates tau-induced neurodegeneration in Drosophila

31 March 2020

1 reference

Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity

31 March 2020

1 reference

TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model.

31 March 2020

1 reference

beta-Amyloid induces paired helical filament-like tau filaments in tissue culture

31 March 2020

1 reference

Tau phosphorylation sites work in concert to promote neurotoxicity in vivo

31 March 2020

1 reference

Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.

31 March 2020

1 reference

The role of presenilin cofactors in the gamma-secretase complex

31 March 2020

1 reference

Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype

31 March 2020

1 reference

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

31 March 2020

1 reference

Conformational Abs recognizing a generic amyloid fibril epitope

31 March 2020

1 reference

Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils

31 March 2020

1 reference

Family-based association between Alzheimer's disease and variants in UBQLN1

31 March 2020

1 reference

Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes.

31 March 2020

1 reference

Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease

31 March 2020

1 reference

Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity

31 March 2020

1 reference

Modeling clinically heterogeneous presenilin mutations with transgenic Drosophila.

31 March 2020

1 reference

Modelling neurodegenerative diseases in Drosophila: a fruitful approach?

31 March 2020

1 reference

Gamma-secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila.

31 March 2020

1 reference

Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy

31 March 2020

1 reference

Progressive neurodegeneration in C. elegans model of tauopathy

31 March 2020

1 reference

Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.

31 March 2020

1 reference

SUT-1 enables tau-induced neurotoxicity in C. elegans.

31 March 2020

1 reference

aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation

31 March 2020

1 reference

Genetics of egg-laying in worms.

31 March 2020

1 reference

Presenilin function in Caenorhabditis elegans

31 March 2020

1 reference

Screening for presenilin inhibitors using the free-living nematode, Caenorhabditis elegans.

31 March 2020

1 reference

Functional Genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology

31 March 2020

1 reference

Functional Genomics meets neurodegenerative disorders. Part II: application and data integration

31 March 2020

1 reference

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

31 March 2020

1 reference

Transcriptional profiling reveals strict boundaries between hippocampal subregions

31 March 2020

1 reference

Regional and strain-specific gene expression mapping in the adult mouse brain

31 March 2020

1 reference

Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei

31 March 2020

1 reference

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

31 March 2020

1 reference

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease

31 March 2020

1 reference

Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.

31 March 2020

1 reference

Mitochondrial oxidative stress causes hyperphosphorylation of tau.

31 March 2020

1 reference

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

31 March 2020

1 reference

Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition.

31 March 2020

1 reference

Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.

31 March 2020

1 reference

Gene expression profiling of the tau mutant (P301L) transgenic mouse brain

31 March 2020

1 reference

Tau filament formation in transgenic mice expressing P301L tau.

31 March 2020

1 reference

Role for glyoxalase I in Alzheimer's disease.

31 March 2020

1 reference

Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes

31 March 2020

1 reference

A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration

31 March 2020

1 reference

Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.

31 March 2020

1 reference

Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice

31 March 2020

1 reference

Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E.

31 March 2020

1 reference

In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease

31 March 2020

1 reference

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

31 March 2020

1 reference

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

31 March 2020

1 reference

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

31 March 2020

1 reference

Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography.

31 March 2020

1 reference

19F and 1H MRI detection of amyloid beta plaques in vivo

31 March 2020

1 reference

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

31 March 2020

1 reference

Drug discovery in dementia: the role of rodent models

31 March 2020

1 reference

Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools

31 March 2020

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

31 March 2020

1 reference

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

31 March 2020

1 reference

Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles

31 March 2020

1 reference

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

31 March 2020

1 reference

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

31 March 2020

1 reference

Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.

31 March 2020

1 reference

Active immunization trial in Abeta42-injected P301L tau transgenic mice.

31 March 2020

1 reference

Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model

31 March 2020

1 reference

Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice

31 March 2020

1 reference

Tau is essential to beta -amyloid-induced neurotoxicity

31 March 2020

1 reference

Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models

31 March 2020

1 reference

Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease

31 March 2020

1 reference

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

31 March 2020

1 reference

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice.

31 March 2020

1 reference

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

31 March 2020

1 reference

Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood

31 March 2020

1 reference

Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease

31 March 2020

1 reference

Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model

31 March 2020

1 reference

Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts

31 March 2020

1 reference

Neurodegenerative diseases and oxidative stress

31 March 2020

1 reference

M1 receptors play a central role in modulating AD-like pathology in transgenic mice

31 March 2020

1 reference

Calpain inhibitors: a treatment for Alzheimer's disease

31 March 2020

1 reference

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production

31 March 2020

1 reference

Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles

31 March 2020

1 reference

Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.

31 March 2020

1 reference

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

31 March 2020

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

31 March 2020

1 reference

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

31 March 2020

1 reference

Abeta40 protects non-toxic Abeta42 monomer from aggregation

31 March 2020

1 reference

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

31 March 2020

1 reference

Reconstitution of gamma-secretase activity

31 March 2020

1 reference

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

31 March 2020

1 reference

The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.

31 March 2020

1 reference

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

31 March 2020

1 reference

A specific amyloid-beta protein assembly in the brain impairs memory

31 March 2020

1 reference

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

31 March 2020

1 reference

Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

31 March 2020

1 reference

Control of peripheral nerve myelination by the beta-secretase BACE1

31 March 2020

1 reference

The effects of a neuregulin 1 variant on white matter density and integrity

31 March 2020

1 reference

Alzheimer disease: BACE1 branches out.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRN2420

1 reference

PubMed ID

18568014

Dimensions Publication ID

18 August 2017

0 references

1 reference

PubMed ID

18568014